Ralph B. Arlinghaus
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Cell Biology, Biostatistics Biology, Genetics, OncologyGoogle:
"Ralph Arlinghaus"Parents
Sign in to add mentor| Milan Alexander Logan | grad student | 1961 | University of Cincinnati (Chemistry Tree) | |
| (Studies on a new amino acid isolated from collagen : sequence studies of peptides obtained from enzymatic hydrolysates of collagen) | ||||
Children
Sign in to add trainee| John J. Kopchick | grad student | 1980 | The University of Texas Graduate School of Biomedical Sciences at Houston (Chemistry Tree) |
| Shanhai Xie | grad student | 2002 | The University of Texas Graduate School of Biomedical Sciences at Houston (Chemistry Tree) |
| Jacki Lin | grad student | 2008 | The University of Texas Graduate School of Biomedical Sciences at Houston (Chemistry Tree) |
| Tian Ding | grad student | 2009 | The University of Texas Graduate School of Biomedical Sciences at Houston (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chappell WH, Candido S, Abrams SL, et al. (2018) Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines. Advances in Biological Regulation |
| Chakraborty SN, Leng X, Perazzona B, et al. (2016) Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia. Genes & Cancer. 7: 201-8 |
| Mu C, Wu X, Ma H, et al. (2016) Effective concentration of a multi-kinase inhibitor within bone marrow correlates with in vitro cell killing in therapy-resistant chronic myeloid leukemia. Molecular Cancer Therapeutics |
| Ochieng J, Nunomura S, Lang W, et al. (2016) Abstract 1124: Expression of the lipocalin 2 oncogene in the development of smoking-associated and Kras mutant lung adenocarcinoma Cancer Research. 76: 1124-1124 |
| Tao W, Chakraborty SN, Leng X, et al. (2015) HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells. Genes & Cancer. 6: 19-29 |
| Mallampati S, Leng X, Ma H, et al. (2015) Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia. Blood. 125: 2968-73 |
| Ma H, Mallampati S, Lu Y, et al. (2014) The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia. Haematologica. 99: 1591-8 |
| Tao W, Leng X, Chakraborty SN, et al. (2014) c-Abl activates janus kinase 2 in normal hematopoietic cells. The Journal of Biological Chemistry. 289: 21463-72 |
| Neviani P, Harb JG, Oaks JJ, et al. (2013) PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. The Journal of Clinical Investigation. 123: 4144-57 |
| Oaks JJ, Santhanam R, Walker CJ, et al. (2013) Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 122: 1923-34 |